178 related articles for article (PubMed ID: 31505737)
1. FMK, an Inhibitor of p90RSK, Inhibits High Glucose-Induced TXNIP Expression via Regulation of ChREBP in Pancreatic β Cells.
Han JH; Kim S; Kim S; Lee H; Park SY; Woo CH
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505737
[TBL] [Abstract][Full Text] [Related]
2. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.
Kibbe C; Chen J; Xu G; Jing G; Shalev A
J Biol Chem; 2013 Aug; 288(32):23194-202. PubMed ID: 23803610
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase (AMPK) mediates nutrient regulation of thioredoxin-interacting protein (TXNIP) in pancreatic beta-cells.
Shaked M; Ketzinel-Gilad M; Cerasi E; Kaiser N; Leibowitz G
PLoS One; 2011; 6(12):e28804. PubMed ID: 22194917
[TBL] [Abstract][Full Text] [Related]
4. ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
Chen N; Song S; Yang Z; Wu M; Mu L; Zhou T; Shi Y
J Diabetes Complications; 2021 Dec; 35(12):108050. PubMed ID: 34600826
[TBL] [Abstract][Full Text] [Related]
5. Glucose-stimulated expression of Txnip is mediated by carbohydrate response element-binding protein, p300, and histone H4 acetylation in pancreatic beta cells.
Cha-Molstad H; Saxena G; Chen J; Shalev A
J Biol Chem; 2009 Jun; 284(25):16898-16905. PubMed ID: 19411249
[TBL] [Abstract][Full Text] [Related]
6. Islet ChREBP-β is increased in diabetes and controls ChREBP-α and glucose-induced gene expression via a negative feedback loop.
Jing G; Chen J; Xu G; Shalev A
Mol Metab; 2016 Dec; 5(12):1208-1215. PubMed ID: 27900263
[TBL] [Abstract][Full Text] [Related]
7. [Angiotensin II promotes the expression of TXNIP through angiotensin II type 1 receptor in islet β cells].
Feng YJ; Wang J; Cao ZJ; Li D; Huo HY; Zhang XM; Jiao XY
Sheng Li Xue Bao; 2018 Apr; 70(2):149-157. PubMed ID: 29691579
[TBL] [Abstract][Full Text] [Related]
8. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.
Boergesen M; Poulsen Ll; Schmidt SF; Frigerio F; Maechler P; Mandrup S
J Biol Chem; 2011 Apr; 286(15):13214-25. PubMed ID: 21282101
[TBL] [Abstract][Full Text] [Related]
9. Elevated Carbohydrate Response Element-Binding Protein Beta (ChREBPβ) and Thioredoxin Interacting Protein (TXNIP) Levels in Human Adipocytes Differentiated in High Glucose Concentrations.
Peshdary V; Gagnon A; Landry A; Ma L; Sorisky A
Can J Diabetes; 2019 Apr; 43(3):215-220. PubMed ID: 30551936
[TBL] [Abstract][Full Text] [Related]
10. Geniposide inhibits glucolipotoxicity and cooperates with Txnip knockdown to potentiate cell adaption to endoplasmic reticulum stress in pancreatic beta cells.
Liu M; Liu C; Shen S; Liu J; Yin F
Cell Biol Int; 2020 Jul; 44(7):1535-1543. PubMed ID: 32215982
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin-interacting protein stimulates its own expression via a positive feedback loop.
Chen J; Jing G; Xu G; Shalev A
Mol Endocrinol; 2014 May; 28(5):674-80. PubMed ID: 24628418
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate response element-binding protein regulates lipid metabolism via mTOR complex1 in diabetic nephropathy.
Chen N; Mu L; Yang Z; Du C; Wu M; Song S; Yuan C; Shi Y
J Cell Physiol; 2021 Jan; 236(1):625-640. PubMed ID: 32583421
[TBL] [Abstract][Full Text] [Related]
13. Role of glucose-6-phosphate and xylulose-5-phosphate in the regulation of glucose-stimulated gene expression in the pancreatic β cell line, INS-1E.
Iizuka K; Wu W; Horikawa Y; Takeda J
Endocr J; 2013; 60(4):473-82. PubMed ID: 23257733
[TBL] [Abstract][Full Text] [Related]
14. mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress.
Chau GC; Im DU; Kang TM; Bae JM; Kim W; Pyo S; Moon EY; Um SH
J Cell Biol; 2017 Jul; 216(7):2091-2105. PubMed ID: 28606928
[TBL] [Abstract][Full Text] [Related]
15. New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells.
Li X; Kover KL; Heruth DP; Watkins DJ; Moore WV; Jackson K; Zang M; Clements MA; Yan Y
Mol Endocrinol; 2015 Aug; 29(8):1184-94. PubMed ID: 26147751
[TBL] [Abstract][Full Text] [Related]
16. Expression and pathophysiological significance of carbohydrate response element binding protein (ChREBP) in the renal tubules of diabetic kidney.
Suzuki S; Yokoyama A; Noro E; Aoki S; Shimizu K; Shimada H; Sugawara A
Endocr J; 2020 Mar; 67(3):335-345. PubMed ID: 31813922
[TBL] [Abstract][Full Text] [Related]
17. [Thioredoxin-interacting protein: a new potential target for diabetes and related vascular complications therapy].
Wu P; Du GH
Yao Xue Xue Bao; 2015 Dec; 50(12):1559-64. PubMed ID: 27169277
[TBL] [Abstract][Full Text] [Related]
18. Glucose-induced nuclear shuttling of ChREBP is mediated by sorcin and Ca(2+) ions in pancreatic β-cells.
Noordeen NA; Meur G; Rutter GA; Leclerc I
Diabetes; 2012 Mar; 61(3):574-85. PubMed ID: 22338092
[TBL] [Abstract][Full Text] [Related]
19. High glucose-induced O-GlcNAcylated carbohydrate response element-binding protein (ChREBP) mediates mesangial cell lipogenesis and fibrosis: the possible role in the development of diabetic nephropathy.
Park MJ; Kim DI; Lim SK; Choi JH; Han HJ; Yoon KC; Park SH
J Biol Chem; 2014 May; 289(19):13519-30. PubMed ID: 24616092
[TBL] [Abstract][Full Text] [Related]
20.
Chen K; Lang H; Wang L; Liu K; Zhou Y; Mi M
Nutr Metab (Lond); 2020; 17():7. PubMed ID: 31956333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
